psa recurrence, risk assessment - 2021 prostate cancer patient conference
Published 3 years ago • 8.1K plays • Length 23:30Download video MP4
Download video MP3
Similar videos
-
27:01
risk assessment of psa recurrent prostate cancer
-
48:23
recurrent prostate cancer cases - 2021 prostate cancer patient conference
-
14:20
prostate cancer epidemiology, screening and diagnosis - 2021 prostate cancer patient conference
-
11:39
oligometastatic disease - 2021 prostate cancer patient conference
-
31:51
disease location, imaging, and risk assessment - 2019 prostate cancer patient conference
-
6:39
psa recurrence: when should you treat? | ask a prostate expert, mark scholz, md
-
18:26
psma & newly-diagnosed #prostatecancer | markscholzmd #alexscholz #pcri
-
9:27
remission and cure after relapse prostate cancer | mark scholz, md | pcri
-
14:34
introduction - 2021 prostate cancer patient conference
-
9:54
systemic therapy options for "psa only" disease - 2021 prostate cancer patient conference
-
21:09
evaluation and management of psa recurrence after definitive treatment of localized prostate cancer
-
12:25
psma pet and functional imaging - 2021 prostate cancer patient conference
-
16:45
untreated metastatic prostate cancer - 2021 prostate cancer patient conference
-
36:19
localized prostate cancer: risk stratification - 2021 prostate cancer patient conference
-
22:55
recurrent prostate cancer cases panel
-
17:37
localized prostate cancer: surgery - 2021 prostate cancer patient conference
-
8:10
an introduction to clinical trials - 2021 prostate cancer patient conference
-
15:49
adt resistant non-metastatic prostate cancer (nmcrpc) - 2021 prostate cancer patient conference
-
34:43
prostate cancer: evaluation and management of low risk disease
-
17:05
psma targeting for treatment of advanced prostate cancer - 2021 prostate cancer patient conference
-
11:09
race, racism and prostate cancer disparities - 2021 prostate cancer patient conference